- Direction
- Inflecting
- Own history
- —
- Peers
- 58th
- Persistence
- REVERSING
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTIRADIMED CORP's latest supported as-filed period reports revenue of $24.2M; gross margin moved 410 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.54% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 28.91% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 14.15% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 55.72% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 76.25% · CORE
Level · gp.fundamentals.operating_margin
Raw value 33.63% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Gross margin moved 410 bp lower; Operating margin moved 203 bp lower.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 14.2%; Operating margin moved 140 bp higher; Operating income increased 19.1%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 9.4%; Inventory / revenue moved 501 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 0.3%; Operating margin moved 203 bp lower; Operating income decreased 5.8%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 12.0%; Operating cash flow increased 0.2%.
2 evidence-backed componentsGross margin changed -410 basis points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
IRMD · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001628280-26-068576SEC ↗8-KOct 30, 2026Period Oct 30, 20260001628280-26-068454SEC ↗4Sep 25, 2026Period Sep 23, 20260001228621-26-000003SEC ↗4Sep 8, 2026Period Sep 3, 20260001253352-26-000010SEC ↗8-K/AAug 18, 2026Period Jul 31, 20260001628280-26-057617SEC ↗10-QJul 31, 2026Period Jun 30, 20260001628280-26-051402SEC ↗8-KJul 31, 2026Period Jul 31, 20260001628280-26-051240SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 23, 2026Filed Sep 25, 2026 | KIANI JOE EDirector | Option ExerciseDirect | 698 | — | — | Form 4 ↗ |
| Sep 23, 2026Filed Sep 25, 2026 | KIANI JOE EDirector | Option ExerciseDirect | 698 | $0 | $0 | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | ALLEN MONTY KDirector | Open Market SaleDirect | 1,014 | $86 | $87,650 | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | ALLEN MONTY KDirector | Open Market SaleDirect | 405 | $86 | $34,972 | Form 4 ↗ |
| Jun 20, 2026Filed Jun 23, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 3.62% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 3.21% · OPTIONAL
Operating income changed +19.1% from the comparable as-filed period.
Capex / revenue changed -1201 basis points from the comparable as-filed period.
Capex / revenue changed -483 basis points from the comparable as-filed period.
Capital expenditure changed -93.0% from the comparable as-filed period.
Inventory / revenue changed +501 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -23.3% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001628280-26-045059| Tax WithholdingDirect |
| 2,319 |
| $92 |
| $213,812 |
| Form 4 ↗ |
| Jun 20, 2026Filed Jun 23, 2026 | GLENN JOHNCFO | Option ExerciseDirect | 5,796 | $0 | $0 | Form 4 ↗ |
| Jun 20, 2026Filed Jun 23, 2026 | GLENN JOHNCFO | Option ExerciseDirect | 5,796 | — | — | Form 4 ↗ |